Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

CAPR Investor Reminder: Capricor Therapeutics Securities Fraud Class Action after 64% Stock Drop is Pending – Investors Notified to Contact BFA Law before September 28 Deadline

Topics Lawsuit

September 17, 2026

From Bleichmar Fonti & Auld LLP

Via Business Wire

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm to Learn About Their Legal Rights

September 16, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Kaplan Fox Reminds Investors of the September 28, 2026 Deadline in the Securities Class Action Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)

Topics Lawsuit

September 16, 2026

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

September 15, 2026

From Kahn Swick & Foti, LLC

Kaplan Fox Alerts Investors to an Upcoming Deadline of September 28, 2026 in the Capricor Therapeutics, Inc. (NASDAQ: CAPR) Securities Class Action

September 15, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR

Topics Lawsuit

September 15, 2026

From Pomerantz LLP

CAPRICOR THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 28, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

September 15, 2026

From Bernstein Liebhard LLP

Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026

September 15, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Kaplan Fox & Kilsheimer LLP Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before September 28, 2026

Topics Lawsuit

September 14, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

CAPR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026

Topics Lawsuit

September 14, 2026

From Faruqi & Faruqi LLP

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

September 14, 2026

From Schall, Brown & Schwartz LLP

Kaplan Fox Announces the Lead Plaintiff Deadline of September 28, 2026 in the Securities Class Action Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)

September 14, 2026

Kodiak Sciences, Capricor Therapeutics and Invivyd each face pivotal clinical trial or FDA decisions before the end of 2026 that could significantly move their stock prices.

3 Small-Cap Biotechs With Binary Catalysts on the Calendar ↗

September 13, 2026

Via MarketBeat

Kaplan Fox Class Action Reminder: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Lead Plaintiff Deadline is September 28, 2026

September 11, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to an Approaching Lead Plaintiff Deadline on September 28, 2026

Topics Lawsuit

September 11, 2026

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit against Capricor Therapeutics, Inc. (NASDAQ: CAPR) is September 28, 2026

September 10, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

CAPRICOR DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CAPR

Topics Fraud Lawsuit

September 10, 2026

From The Rosen Law Firm PA

CAPRICOR THERAPEUTICS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 28, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline

September 10, 2026

From Bernstein Liebhard LLP

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

September 10, 2026

From Schall, Brown & Schwartz LLP

Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026

September 10, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR

Topics Lawsuit

September 09, 2026

From SkyMedia, LLC

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026

September 09, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm Before the Securities Class Action Deadline on September 28, 2026

Topics Lawsuit

September 09, 2026

LAWSUIT INVESTOR NOTICE: Investors who lost money with Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares should contact the Shareholders Foundation

September 09, 2026

From The Shareholders Foundation, Inc.

Via Business Wire

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

September 08, 2026

From Kahn Swick & Foti, LLC

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 28, 2026

September 08, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm

Topics Lawsuit

September 08, 2026

From Bragar Eagel & Squire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR

September 08, 2026

From Pomerantz LLP

Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026

September 08, 2026

NEW YORK, NY - September 8, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (“Capricor” or the “Company”)...